In this issue:
- CV outcomes after RYGB, sleeve gastrectomy or usual care
- Real-world medication persistence in type 2 diabetes
- CV outcomes of glucose-lowering drugs
- Identifying adults at high-risk for change in weight and BMI
- Weight regain after a behavioural weight loss programme ends
- Long-term complications in youth-onset type 2 diabetes
- Effects of preventative lifestyle intervention on glycaemic control for type 2 diabetes
- Clinical and psychosocial characteristics of adults with DKA and type 1 diabetes
- Glucose control during COVID-19 lockdowns
- Outcomes for type 1 diabetics hospitalised for COVID-19
- Glycaemic control and drug use trends in type 2 diabetes
- CV disease incidence trends in type 1 diabetics in Finland
- BMI and pneumonia outcomes in critically ill COVID-19 patients
- COVID-19 vaccines in obesity
Please login below to download this issue (PDF)